When the protein cannot be brought to its correct state through refolding mechanisms, structural alterations in the N-glycan lead to its recognition by specific receptors, such as Osteosarcoma-9 (OS-9) and XTP3-transactivated Protein B (XTP3-B). This evidence concerns the gene ERLEC1 and osteosarcoma.